Skip to main content
. Author manuscript; available in PMC: 2019 Jan 7.
Published in final edited form as: Curr Treatm Opt Rheumatol. 2017 Oct 24;3(4):275–288. doi: 10.1007/s40674-017-0076-9

Table 2.

Diagnosis of PNS manifestation of pSS

Small fiber sensory neuropathy Sensory ataxic neuropathy Sensorimotor axonal neuropathy

Exam Variable length dependence Non-length-dependent Length-dependent
Abnormal pinprick/temperature Pseudoathetosis mild distal weakness
Sensation DTR normal Vibratory sense normal Abnormal proprioception Abnormal vibration Reduced DTR Abnormal Rombergs Test Decreased or absent DTR
Neurodiagnostics NCS/EMG: NCS: NCS:
Normal Low amplitude or unelicitable SEPs and SNAPs involving central/periphral rami of sensory neurons Motor nerve conduction normal (may be more frequently abnormal in paraneoplastic syndromes) CMAP/SNAP amplitude reduction Conduction velocity: normal/slightly prolonged
Other Skin biopsy MRI: Further evaluation
Quantitative sensory test T2 hyperintensity of posterior Nerve biopsy
for thermal sensations Laser evoked potentials Electrochemical skin conductance Sympathetic skin response columns Cryoglobulins
Differential Diabetes mellitus or HIV Diabetes Mellitus
diagnosisa,b,c imparied glucose tolerance Malignancy/paraneoplastic Thyroid disease
Hyperlipidemia Bickerstaffs brainstem Uremia
Celiac disease encephalitis Tox’ns (alcohol, drugs)
Infection (ie HIV) Toxins (drugs, alcohol) Other autoimmune (ie amyloidosis) Hereditary Monoclonal gammopathy or Paraneoplastic syndrome Idiopathic Drugs (cisplatin, pyridox’ne) Vitamin deficiency (B1, B12) Vasculitis Sarcoidosis Other autoimmune (SLE) Paraneoplastic syndrome Infection (HIV, Lyme disease, Leprosy) Porphyria

DTR deep tendon reflexes, NCS nerve conduction studies, EMG electromyography, SEP somatosensory evoked potential, SNAP sensory nerve action potential, CMAP compound muscle action potential

a

Birnbaum J. Peripheral nervous system manifestations of Sjogren syndrome: clinical patterns, diagnostic paradigms, etiopathogenesis, and therapeutic strategies. Neurologist. 2010;16(5):287-97

b

Mauermann ML et al. The evaluation of chronic axonal polyneuropathies. Semin Neurol. 2008;28(2):133-51

c

Lauria G. Small fiber neuropathies. Curr Opin Neurol. 2005;18(5):591-7